Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
---|
Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
---|
Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
---|
U.S. stocks were mixed, with the Dow Jones index gaining over 250 points on Tuesday.
Shares of Mesoblast Limited (NASDAQ:MESO) rose sharply during Tuesday's session after the company announced alignment with the U.S. Food and Drug Administration (FDA) on items required for filing a Biologics License Application (BLA) for Revascor (rexlemestrocel-L) for ischemic heart failure with reduced ejection fraction (HFrEF) and inflammation.
Mesoblast shares jumped 11.8% to $12.18 on Tuesday.
Here are some other big stocks recording gains in today’s session.
Now Read This:
Photo via Shutterstock
Posted In: AAP ATAI BLMN CTOR IREN LVS MESO MLCO MSC MUX WYNN